QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: jpet.106.118125v1 321/2/734    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Newton, R. Articles by Barnes, P. J. Search for Related Content PubMed PubMed Citation Articles by Newton, R. Articles by Barnes, P. J.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule IB Kinase Inhibitors

Respiratory Research Group, Departments of Cell Biology and Anatomy, Physiology and Biophysics, and Medicine, University of Calgary, Calgary, Alberta, Canada (R.N., N.S.H., W.O., R.L., D.P.); and National Heart and Lung Institute, Imperial College London, London, United Kingdom (M.C.C., P.J.B.)

The airway epithelium is critical in the pathogenesis of chronic inflammatory diseases, such as asthma and chronic obstructive pulmonary disease, and, by expressing numerous inflammatory genes, plays a prominent role in disease exacerbations. Since inflammatory gene expression often involves the transcription factor nuclear factor (NF)-B, this signaling pathway represents a site for anti-inflammatory intervention. As the airway epithelium is targeted by inhaled therapeutic agents, for example corticosteroids, human A549 pulmonary cells and primary human bronchial epithelial (HBE) cells were selected to evaluate inhibitor of B kinase (IKK) inhibitors. In A549 cells, interleukin (IL)-1 and tumor necrosis factor (TNF) increased phosphorylation of IB, and this was followed by loss of IB, induction of NF-B DNA binding, and the induction of NF-B-dependent transcription. These events were repressed by the IKK-selective inhibitors, PS-1145 [N-(6-chloro-9H--carbolin-8-ly) nicotinamide] and ML120B [N-(6-chloro-7-methoxy-9H--carbolin-8-yl)-2-methyl-nicotinamide]. Inhibition of NF-B-dependent transcription was concentration-dependent and correlated with loss of intercellular adhesion molecule (ICAM)-1 expression. Similarly, IL-1- and TNF-induced expression of IL-6, IL-8, granulocyte macrophage-colony-stimulating factor (GM-CSF), regulated and activation normal T cell expressed and secreted (RANTES), growth-related oncogene , and monocyte chemotactic protein-1 (MCP-1) was also significantly repressed. Likewise, PS-1145 and ML120B profoundly reduced NF-B-dependent transcription induced by IL-1 and TNF in primary HBE cells. Parallel effects on ICAM-1 expression and a significant repression of IL-8 release were observed. In contrast, the corticosteroid, dexamethasone, was without effect on NF-B-dependent transcription or the expression of ICAM-1. The above data provide strong support for an anti-inflammatory effect of IKK2 inhibitors acting on the pulmonary epithelium and suggest that such compounds may prove beneficial in situations where traditional corticosteroid therapies prove inadequate.

Address correspondence to: Dr. Robert Newton, Department of Cell Biology and Anatomy, Respiratory Research Group, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail: rnewton{at}ucalgary.ca

This article has been cited by other articles:

				E. M. King, N. S. Holden, W. Gong, C. F. Rider, and R. Newton Inhibition of NF-{kappa}B-dependent Transcription by MKP-1: TRANSCRIPTIONAL REPRESSION BY GLUCOCORTICOIDS OCCURRING VIA p38 MAPK J. Biol. Chem., September 25, 2009; 284(39): 26803 - 26815. [Abstract] [Full Text] [PDF]

				L. Cakarova, L. M. Marsh, J. Wilhelm, K. Mayer, F. Grimminger, W. Seeger, J. Lohmeyer, and S. Herold Macrophage Tumor Necrosis Factor-{alpha} Induces Epithelial Expression of Granulocyte-Macrophage Colony-stimulating Factor: Impact on Alveolar Epithelial Repair Am. J. Respir. Crit. Care Med., September 15, 2009; 180(6): 521 - 532. [Abstract] [Full Text] [PDF]

				P. C. Sanghani, W. I. Davis, S. L. Fears, S.-L. Green, L. Zhai, Y. Tang, E. Martin, N. S. Bryan, and S. P. Sanghani Kinetic and Cellular Characterization of Novel Inhibitors of S-Nitrosoglutathione Reductase J. Biol. Chem., September 4, 2009; 284(36): 24354 - 24362. [Abstract] [Full Text] [PDF]

				E. M. King, M. Kaur, W. Gong, C. F. Rider, N. S. Holden, and R. Newton Regulation of Tristetraprolin Expression by Interleukin-1{beta} and Dexamethasone in Human Pulmonary Epithelial Cells: Roles for Nuclear Factor-{kappa}B and p38 Mitogen-Activated Protein Kinase J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 575 - 585. [Abstract] [Full Text] [PDF]

				C. D. Sommers, J. M. Thompson, J. A. Guzova, S. L. Bonar, R. K. Rader, S. Mathialagan, N. Venkatraman, V. W. Holway, L. E. Kahn, G. Hu, et al. Novel Tight-Binding Inhibitory Factor-{kappa}B Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 377 - 388. [Abstract] [Full Text] [PDF]

				P. Seidel, I. Merfort, J. M. Hughes, B. G. G. Oliver, M. Tamm, and M. Roth Dimethylfumarate inhibits NF-{kappa}B function at multiple levels to limit airway smooth muscle cell cytokine secretion Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L326 - L339. [Abstract] [Full Text] [PDF]

				Z. Bao, S. Guan, C. Cheng, S. Wu, S. H. Wong, D. M. Kemeny, B. P. Leung, and W. S. F. Wong A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-{kappa}B Pathway Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 657 - 665. [Abstract] [Full Text] [PDF]

				S. J. Moghaddam, H. Li, S.-N. Cho, M. K. Dishop, I. I. Wistuba, L. Ji, J. M. Kurie, B. F. Dickey, and F. J. DeMayo Promotion of Lung Carcinogenesis by Chronic Obstructive Pulmonary Disease-Like Airway Inflammation in a K-ras-Induced Mouse Model Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 443 - 453. [Abstract] [Full Text] [PDF]

				B. D. Medoff, A. L. Landry, K. A. Wittbold, B. P. Sandall, M. C. Derby, Z. Cao, J. C. Adams, and R. J. Xavier CARMA3 Mediates Lysophosphatidic Acid-Stimulated Cytokine Secretion by Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., March 1, 2009; 40(3): 286 - 294. [Abstract] [Full Text] [PDF]

				M.-I. Kang, C. J. Henrich, H. R. Bokesch, K. R. Gustafson, J. B. McMahon, A. R. Baker, M. R. Young, and N. H. Colburn A selective small-molecule nuclear factor-{kappa}B inhibitor from a high-throughput cell-based assay for "activator protein-1 hits" Mol. Cancer Ther., March 1, 2009; 8(3): 571 - 581. [Abstract] [Full Text] [PDF]

				K. Liu, G. P. Anderson, and S. Bozinovski DNA Vector Augments Inflammation in Epithelial Cells via EGFR-Dependent Regulation of TLR4 and TLR2 Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 305 - 311. [Abstract] [Full Text] [PDF]

				A. Zanini, A. Chetta, and D. Olivieri Review: Therapeutic perspectives in bronchial vascular remodeling in COPD Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 179 - 187. [Abstract] [PDF]

				S. J. Tudhope, M. C. Catley, P. S. Fenwick, R. E. K. Russell, W. L. Rumsey, R. Newton, P. J. Barnes, and L. E. Donnelly The Role of I{kappa}B Kinase 2, but Not Activation of NF-{kappa}B, in the Release of CXCR3 Ligands from IFN-{gamma}-Stimulated Human Bronchial Epithelial Cells J. Immunol., November 1, 2007; 179(9): 6237 - 6245. [Abstract] [Full Text] [PDF]

				Z. Bao, S. Lim, W. Liao, Y. Lin, C. Thiemermann, B. P. Leung, and W. S. F. Wong Glycogen Synthase Kinase-3beta Inhibition Attenuates Asthma in Mice Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 431 - 438. [Abstract] [Full Text] [PDF]